Benzinga’s Volume Movers (DNDN, DBRN, YUII, ROVI, ITMN)
Dendreon Corporation (NASDAQ: DNDN) shares gained 6.12% to $34.50. The volume of DNDN shares traded was 1,854% higher than normal. DNDN is experimenting on a cancer vaccine, Provenge, which would be the first cancer vaccine aimed at treating a condition, rather than preventing a disease like traditional vaccines do. Read more about this company here.
Dress Barn Inc (NASDAQ: DBRN) shares climbed 3.93% to $26.74. The volume of DBRN shares traded was 311% higher than normal. The acquisition of the Justice brand had helped DBRN return to profits in Q2 from a loss in the same quarter a year ago. Read more about this company here.
Yuhe International Inc (NASDAQ: YUII) shares jumped 6.97% to $11.35. The volume of YUII shares traded was 299% higher than normal. YUII engages in the supply of day-old chickens raised for meat production or broilers in China. Read more about this company here.
Rovi Corporation (NASDAQ: ROVI) shares rose 4.55% to $34.95. The volume of ROVI shares traded was 240% higher than normal. ROVI has recently announced its expansion of data and patent license agreement with Comcast (NASDAQ: CMCSA). Read more about this company here.
InterMune Inc (NASDAQ: ITMN) shares moved up 5.46% to $15.44. The volume of ITMN shares traded was 238% higher than normal. ITMN has submitted a Marketing Authorization Application (MAA) to seek approval for marketing pirfenidone for the treatment of patients suffering from idiopathic pulmonary fibrosis. Read more about this company here.
